Vertical: HealthcareBase Year: 202419 Sections
Market Size (2024)
$1.50B
Projected (2035)
$5.21B
CAGR (2019–2035)
11.0%
Key Players
10+
This report covers India Digital Diabetes Management Market with forecasts from 2019 to 2035. 10 key companies are profiled.
The India Digital Diabetes Management Market market is projected to grow at a CAGR of 11.0% from 2019 to 2035.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
Rising diabetes prevalence across India, strong government support, and digital health initiatives, along with an increasing number of product launches, are driving the growth of the India Digital Diabetes Management Market. However, the high costs of digital solutions and concerns around data privacy and security are expected to hamper market expansion. Nevertheless, the growing geriatric population and the increasing number of awareness campaigns across India are anticipated to create lucrative opportunities for the industry.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2024
Historical Period
2019 – 2023
Forecast Period
2025 – 2035
Primary Interviews
150+
Historical data (2019–2024) and forecast period (2024–2035)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMichael Porter's Five Forces model is a framework to study the India digital diabetes management market. Strategic business managers trying to gain an edge over competing firms in the India digital diabetes management market can utilize this model to better comprehend the industry in which the firm operates. The components of each of the forces and the degree of impact of each component in the context of the India digital diabetes management market have been broken down and analyzed.
PORTER'S FIVE FORCES Analysis: India digital diabetes management market
Threat of New Entrants
The threat of new entrants in the India digital diabetes management market is moderate. While technological advancements lower entry barriers, the complex regulatory landscape and capital requirements for developing quality products can deter new players. Established brands already dominate the market, with strong consumer trust and extensive resources, making it difficult for newcomers to gain significant market share quickly.
BARGAINING POWER OF SUPPLIERS
The bargaining power of suppliers is moderate to high. For digital health solutions, suppliers of technology, software, and hardware (e.g., sensors, wearables) have considerable influence, especially as the market grows. Key players in medical devices (e.g., CGMs, insulin pumps) have greater bargaining power due to their specialized products. As demand rises, suppliers of essential components may increase prices, further elevating their leverage.
Threat of Substitutes
The threat of substitutes is moderate. While traditional diabetes management methods like manual blood glucose monitoring and lifestyle changes remain prevalent, digital tools offer significant advantages in terms of real-time data, remote monitoring, and personalization. However, in rural areas or among cost-sensitive consumers, cheaper, traditional methods can still be a preferred alternative, which limits the impact of substitutes.
Bargaining Power of Buyers
The bargaining power of buyers is relatively high. With numerous digital diabetes management solutions available, consumers can easily compare products based on price, features, and effectiveness. India’s price-sensitive market gives buyers the leverage to choose low-cost options or free apps. Additionally, insurance companies’ growing involvement in covering digital health tools further strengthens consumers' bargaining power.
Intensity of Rivalry
The intensity of rivalry in the India digital diabetes management market is high. The market is highly competitive, with established multinational companies and emerging startups fighting for market share. Key players compete on technology, innovation, affordability, and user experience. Rapid product development, frequent new entrants, and the increasing demand for diabetes management solutions ensure that rivalry remains intense.
Key Market Trends
The India digital diabetes management market is undergoing a transformative shift, driven by rapid technological adoption, increasing healthcare digitization, and growing patient demand for convenient, personalized care. The proliferation of health platforms and mobile apps like BeatO and Sugar.fit has made real-time monitoring and coaching accessible, especially in Tier 2 and 3 cities. At the same time, the expansion of telemedicine and remote monitoring, catalyzed by the COVID-19 pandemic, has bridged critical gaps in specialist care, particularly in rural areas. Advances in AI and big data are enabling hyper-personalized treatment plans, while both government programs and private sector initiatives are fostering a supportive ecosystem for digital health innovation. The rising availability and affordability of CGM systems and smart insulin devices further underscore the market’s movement toward precision-driven, tech-enabled diabetes management.
Growth of Digital Health Platforms & Apps
The digital diabetes management market in India is witnessing significant growth due to the rapid adoption of health platforms and mobile apps. Apps like BeatO, Sugar.fit, and Fitterfly are gaining popularity for features such as real-time glucose tracking, AI-driven dietary recommendations, and personalized coaching. These platforms cater to both Type 1 and Type 2 diabetes patients, offering convenience and reducing dependency on traditional clinic visits. The increasing affordability of internet services and the rise of regional language apps are further driving adoption in Tier 2 and Tier 3 cities, making diabetes management more accessible across India.
Telemedicine & Remote Monitoring Expansion
Telemedicine has become a cornerstone of diabetes care in India, especially after the COVID-19 pandemic. Platforms like Practo, MFine, and Tata 1mg provide virtual consultations with endocrinologists and nutritionists, addressing the shortage of specialists in rural areas. Remote monitoring tools, such as connected glucometers and wearable devices, enable doctors to track patient data in real time and adjust treatment plans accordingly. This shift towards hybrid healthcare models—combining in-person and digital care—is improving patient outcomes while reducing hospital visits, making diabetes management more efficient and scalable.
AI & Big Data for Personalized Care
Artificial Intelligence (AI) and big data analytics are revolutionizing diabetes care by enabling personalized treatment plans. AI-powered platforms like BeatO and Sugar.fit analyze glucose trends, diet, and activity levels to provide predictive insights and automated alerts for hypoglycemia or hyperglycemia risks. Machine learning algorithms help in tailoring insulin dosages and lifestyle recommendations, improving adherence and outcomes. Additionally, integration with wearable devices and electronic health records (EHRs) ensures seamless data flow, allowing for data-driven decision-making in diabetes management.
Government & Private Sector Initiatives
The Indian government is actively promoting digital diabetes management through initiatives like the Ayushman Bharat Digital Mission (ABDM) and the National Programme for Prevention & Control of Non-Communicable Diseases (NP-NCD), which encourage digital health records and remote monitoring. Private players, including pharmaceutical companies like Novo Nordisk and Sanofi, are collaborating with health-tech startups to develop digital therapeutics (DTx).
Market estimates by geography (2035)
InsightAPAC leads with $1.38M by 2035.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2019 | 2024 | 2035 | CAGR | SHARE |
|---|---|---|---|---|---|
| APAC | $1.38M | $1.38M | $1.38M | N/A | 100% |
| Total | $1.38M | $1.38M | $1.38M | 11.0% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$5.21B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Type 2 Diabetes | $3.55B | 11.1% | 68% |
| Type 1 Diabetes | $1.20B | 9.9% | 23% |
| Gestational Diabetes | $460.29M | 13.8% | 9% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on India Digital Diabetes Management Market covering market dynamics, competitive landscape, and strategic outlook.
The India Digital Diabetes Management Market market is projected to reach $5.21B by 2035, growing at 11.0% CAGR. The Type 2 Diabetes segment holds the largest share.
Introduction
Rising diabetes prevalence across India, strong government support, and digital health initiatives, along with an increasing number of product launches, are driving the growth of the India Digital Diabetes Management Market. However, the high costs of digital solutions and concerns around data privacy and security are expected to hamper market expansion. Nevertheless, the growing geriatric population and the increasing number of awareness campaigns across India are anticipated to create lucrative opportunities for the industry.
Rising Diabetes Prevalence Across INDIA
The rising prevalence of diabetes across India is becoming a major public health concern, driven by factors such as urbanization, sedentary lifestyles, unhealthy diets, and genetic predisposition. For instance, according to the International Diabetes Federation (IDF), India is one of the seven countries and territories within the IDF South-East Asia (SEA) region, which currently accounts for a significant share of the global diabetes burden. Out of the 589 million people living with diabetes worldwide, 107 million are in the SEA region, and this number is projected to rise sharply to 185 million by 2050. In 2024, India’s adult population stands at approximately 947 million, with a diabetes prevalence rate of 10.5% among adults. Moreover, India is one of the seven countries and territories in the IDF South-East Asia Region and holds the distinction of having the second highest number of adults aged 20 to 79 years with diabetes globally. The number of diabetic adults in India has seen a sharp rise over the past two decades, increasing from 32.7 million in 2000 to 61.3 million in 2011. By 2024, this number has reached approximately 89.8 million and is projected to surge to 156.7 million by 2050.
As more individuals are diagnosed with diabetes at younger ages, the need for continuous monitoring, timely intervention, and personalized care is growing rapidly. This shift is significantly boosting the India digital diabetes management market, as patients and healthcare providers increasingly turn to technology-driven solutions for effective disease management. Digital tools like mobile apps, wearable devices, and telehealth platforms enabling better glucose tracking, remote consultations, and real-time health insights. The growing emphasis on preventive care, along with increased awareness and healthcare digitization initiatives, is further accelerating the adoption of digital diabetes management solutions across the country.
Government Support & Digital Health Initiatives
The Indian government's strategic investments and policy-driven initiatives in digital health infrastructure—most notably through the Ayushman Bharat Digital Mission (ABDM), National Digital Health Blueprint, and the broader Digital India campaign—are acting as significant catalysts for the expansion of the digital diabetes management market. These flagship programs are laying the digital foundation necessary for scalable, integrated healthcare delivery by introducing core enablers such as ABHA (Ayushman Bharat Health Account) IDs, interoperable electronic health records (EHRs), telemedicine platforms, and healthcare professional registries.
As of 2024, over 300 million ABHA IDs have been generated, and more than 50 million teleconsultations have been facilitated via e-Sanjeevani, reflecting the rapid maturity of India's digital health ecosystem. This infrastructure is enabling real-time, secure exchange of health data across stakeholders, fostering an ecosystem conducive to innovation in diabetes care—particularly in the areas of AI-powered glucose monitoring, mobile health (mHealth) applications, and continuous glucose monitoring (CGM) systems.
In addition, government-backed platforms such as e-Sanjeevani, the SEHAT initiative, and Common Service Centres (CSCs) are extending digital healthcare services to rural and underserved populations, helping bridge longstanding healthcare access gaps. These efforts are significantly expanding the reach of virtual diabetes consultations, remote monitoring, and ongoing patient engagement.
From a market perspective, India’s digital diabetes segment is poised for accelerated growth, driven by a unique convergence of high disease prevalence, rapid digital adoption, and strong multi-sectoral collaboration. Public-private partnerships (PPPs) are playing a critical role in this transformation. Leading health-tech companies such as BeatO, Sugar.fit, and Fitterfly are actively leveraging ABDM’s digital architecture to deliver personalized, data-driven diabetes solutions at scale.
Looking ahead, emerging technologies like generative AI for predictive diagnostics, 5G-enabled real-time monitoring, and digital therapeutics (DTx) are expected to redefine chronic disease management. The government's forward-looking approach to recognizing DTx and facilitating insurance reimbursement under Ayushman Bharat is poised to drive mass adoption, enhance clinical outcomes, and open new avenues for innovation.
In summary, India is positioning itself as a global leader in the digital diabetes management space. Through strategic policy direction, robust digital infrastructure, and cross-sector collaboration, the country is not only expanding access and improving patient outcomes but also unlocking sustainable growth opportunities across the digital health value chain.
Growing PRODUCT LAUNCH
The India digital diabetes management market is experiencing significant growth, driven by a wave of innovative product launches spanning devices, digital platforms, and integrated AI solutions. For instance, in November 2023, Abbott Laboratories, Inc. (US) launched the FreeStyle LibreLink app in India a digital tool designed for users of the FreeStyle Libre system. This continuous glucose monitoring device is currently utilized by over 500 million people globally. Smart insulin pens and wearable insulin pumps—such as India’s CE-certified “InSul” pump by AgVa and the cost-effective InsuFlo from IISc’s Open MedLabs—are expanding access to precision insulin delivery. On the digital front, AI-driven apps like JoyHealth and platforms such as BeatO CURV, HealthifyMe, and Wellthy’s Duo offer personalized nutrition, lifestyle coaching, and remote monitoring, integrating data across devices to empower both users and clinicians. These product launches not only enrich the digital diabetes management ecosystem but also drive adoption through affordability, local customization, and enhanced data-driven care resulting in stronger market penetration and a projected double-digit CAGR in the coming years.
The growing geriatric population in India is creating lucrative growth opportunities for the digital diabetes management market. As per UN data, individuals aged 6 and above currently constitute around.5% of ndia’s total population—approximately 149 million—and this figure is expected to double to 347 million by 2050. This demographic shift is significant, as aging is closely associated with a higher risk of chronic conditions, particularly type 2 diabetes. Older adults often require continuous monitoring, timely interventions, and personalized care—needs that digital solutions are well-equipped to meet. Technologies such as continuous glucose monitors (CGMs), mobile health apps, and AI-powered platforms enable remote monitoring and real-time data sharing with healthcare providers, reducing the burden of hospital visits and improving quality of life. Additionally, user-friendly interfaces, voice-enabled features, and home-based care integration are making digital tools more accessible for elderly users. As this segment continues to expand, demand for cost-effective, scalable, and senior-friendly diabetes management solutions is e pected to surge, positioning ndia’s digital health ecosystem for robust gro th. India is witnessing a significant surge in national and regional diabetes awareness campaigns, creating substantial growth opportunities within the digital diabetes management market.
Government-led initiatives such as the ’s efeat iabetes Campaign, which screened over 106 million individuals in just 100 days, along with expansive rural outreach programs, have dramatically improved public awareness and early diagnosis rates. This uptick in proactive health engagement is translating into increased demand for digital solutions, including continuous glucose monitors (CGMs), smart glucometers, and remote monitoring tools. Moreover, in August 2024, Danone India and Apollo 24|7 launched the Super 6 Diabetes Program, a digital initiative combining real- time monitoring, expert coaching, and personalized care plans. Central to the program is Protinex Diabetes Care, a low-GI, high- fiber nutritional product designed to support blood sugar control. Targeting ndia’s 77 million diabetics, the program aims to simplify diabetes management through pollo’s digital platform and anone’s nutrition e pertise. Users can enroll online to begin their HbA1c reversal journey with guided, tech-enabled support. In parallel, the implementation of the Ayushman Bharat Digital Mission and the broader Digital India initiative is strengthening the digital healthcare infrastructure, fostering seamless integration of mobile health apps, telemedicine platforms, and real-time data tracking solutions.
This ecosystem is further supported by private sector contributions from global players such as Sanofi, Novo Nordisk, Abbott, and Roche, as well as domestic innovators like BeatO, Wellthy, and GOQii, which are offering AI-driven coaching, device-linked platforms, and personalized digital care plans. Additionally, frequent public screening initiatives and community health camps—such as the U ’s “B × ” Challenge—are driving user adoption of digital health technologies across both urban and rural populations. Collectively, these multi-stakeholder efforts are fostering a rapidly expanding, innovation-friendly market environment. As digital literacy and smartphone penetration continue to rise, the Indian digital diabetes management market is poised for accelerated growth, offering compelling ROI potential for investors, medtech companies, app developers, and digital health providers. – 19 IMPACT The COVID-19 pandemic had a mixed, and in some aspects moderately negative, impact on the digital diabetes management market in India. While it accelerated the adoption of digital health technologies in the long run, the immediate effects of the crisis posed several challenges for patients, providers, and digital health companies.
The sudden nationwide lockdowns disrupted routine healthcare services, leading to delays in diabetes diagnosis, reduced follow-up visits, and poor adherence to treatment regimens, particularly in semi-urban and rural areas where digital infrastructure remains limited. Many patients—especially the elderly and economically disadvantaged—faced difficulties accessing or using telemedicine platforms and mobile health applications due to a lack of digital literacy and technology access. Additionally, the healthcare system was largely redirected toward COVID-19 response, which deprioritized chronic disease management in the early months of the pandemic. Digital diabetes solution providers also experienced operational and financial strain, as supply chain disruptions affected the distribution of monitoring devices like continuous glucose monitors (CGMs) and smart insulin pens. Startups in the space faced funding delays and uncertainty, impacting their growth and scaling plans. While regulatory moves such as the introduction of telemedicine guidelines were a step forward, the sector still struggled with fragmented data systems and lack of interoperability, hindering seamless digital diabetes care delivery during the crisis.
Overall, although the pandemic laid the groundwork for future digital health expansion, its short-term impact on ndia’s digital diabetes management market highlighted critical gaps in accessibility, infrastructure, and digital readiness that must be addressed to ensure inclusive and resilient chronic disease care.
High Costs of Digital Solutions
The high costs of digital diabetes management solutions in global markets have paradoxically fueled the growth of India's digital diabetes management market. While advanced technologies like continuous glucose monitors (CGMs), smart insulin pens, and AI-powered health platforms remain prohibitively expensive in many developed nations, Indian startups have leveraged this gap to develop localized, affordable alternatives priced 60-80% lower. For instance, homegrown CGM systems like Ultrahuman and BeatO offer subscription models as low as USD 15 – USD 30 per month, driving adoption among India’s 77 million diabetic patients, according to India’s Diabetes Atlas, the second-highest globally.
This cost advantage, coupled with rising digital health awareness—accelerated by government initiatives like the National Digital Health Mission (NDHM)—has spurred growth in the sector. Furthermore, foreign investors are capitalizing on this potential, with India’s digital health startups securing funding, focusing on scalable, low-cost solutions.
Data Privacy and Security Concerns
In India’s rapidly growing digital diabetes management sector, data privacy and security have become pressing challenges as adoption surges. With millions of patients now using glucose-tracking apps, wearable devices, and AI-driven platforms, highly sensitive health data—such as real-time blood sugar levels, insulin dosages, and lifestyle patterns—are being collected and stored digitally. A 2023 study by the Indian Council of Medical Research (ICMR) found that nearly 60% of health apps in India lack proper data encryption, leaving patient information vulnerable to leaks or misuse.
While India’s Digital Personal Data Protection Act (2023) provides a foundational framework, enforcement remains inconsistent, particularly for health tech startups. Many diabetes management platforms operate without adhering to ISO 27001 security standards or conducting regular vulnerability audits. According to a 2024 report by the Data Security Council of India (DSCI), healthcare ranked among the top three sectors targeted by cyberattacks, with incidents rising by 30% year-over-year.
Another concern is patient awareness. A survey by NITI Aayog revealed that only 41% of digital health users fully understood how their diabetes data was being stored or shared. Startups like BeatO and Ultrahuman are now implementing stricter measures, such as blockchain-based anonymization and on-shore data storage, to enhance security. Meanwhile, the Ayushman Bharat Digital Mission (ABDM) is working to standardize consent mechanisms and secure health data exchange protocols.
As India’s digital diabetes management market expands, stronger regulatory oversight, patient education, and investment in cybersecurity infrastructure will be essential to protect sensitive health information and maintain user trust.
The growing geriatric population in India is creating lucrative growth opportunities for the digital diabetes management market. As per UNFPA data, individuals aged 60 and above currently constitute around 10.5% of India’s total population—approximately 149 million—and this figure is expected to double to 347 million by 2050. This demographic shift is significant, as aging is closely associated with a higher risk of chronic conditions, particularly type 2 diabetes. Older adults often require continuous monitoring, timely interventions, and personalized care—needs that digital solutions are well-equipped to meet. Technologies such as continuous glucose monitors (CGMs), mobile health apps, and AI-powered platforms enable remote monitoring and real-time data sharing with healthcare providers, reducing the burden of hospital visits and improving quality of life. Additionally, user-friendly interfaces, voice-enabled features, and home-based care integration are making digital tools more accessible for elderly users. As this segment continues to expand, demand for cost-effective, scalable, and senior-friendly diabetes management solutions is expected to surge, positioning India’s digital health ecosystem for robust growth.
Increasing Campaign Across the india
India is witnessing a significant surge in national and regional diabetes awareness campaigns, creating substantial growth opportunities within the digital diabetes management market. Government-led initiatives such as the RSSDI’s Defeat Diabetes Campaign, which screened over 106 million individuals in just 100 days, along with expansive rural outreach programs, have dramatically improved public awareness and early diagnosis rates. This uptick in proactive health engagement is translating into increased demand for digital solutions, including continuous glucose monitors (CGMs), smart glucometers, and remote monitoring tools.
Moreover, in August 2024, Danone India and Apollo 24|7 launched the Super 6 Diabetes Program, a digital initiative combining real-time monitoring, expert coaching, and personalized care plans. Central to the program is Protinex Diabetes Care, a low-GI, high-fiber nutritional product designed to support blood sugar control. Targeting India’s 77 million diabetics, the program aims to simplify diabetes management through Apollo’s digital platform and Danone’s nutrition expertise. Users can enroll online to begin their HbA1c reversal journey with guided, tech-enabled support.
In parallel, the implementation of the Ayushman Bharat Digital Mission and the broader Digital India initiative is strengthening the digital healthcare infrastructure, fostering seamless integration of mobile health apps, telemedicine platforms, and real-time data tracking solutions. This ecosystem is further supported by private sector contributions from global players such as Sanofi, Novo Nordisk, Abbott, and Roche, as well as domestic innovators like BeatO, Wellthy, and GOQii, which are offering AI-driven coaching, device-linked platforms, and personalized digital care plans.
Additionally, frequent public screening initiatives and community health camps—such as the RSSDI UP’s “BP 10×10” Challenge—are driving user adoption of digital health technologies across both urban and rural populations. Collectively, these multi-stakeholder efforts are fostering a rapidly expanding, innovation-friendly market environment.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 106 companies operating in the India Digital Diabetes Management Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
8 interactive charts drawn from the India Digital Diabetes Management Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
India Digital Diabetes Management Market By Tier 2 Cities
India Digital Diabetes Management Market By Tier 1 Cities
India Digital Diabetes Management Market By End Use Settings
India Digital Diabetes Management Market By TYPE
India Digital Diabetes Management Market By Product And Services
India Digital Diabetes Management Market By Patient Type
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
